Hide Board Information

Show Board Information

Currenc Group Inc. CURR

Board Mod: Mauibound

Asst Mods:

Last Post: 07/02/2024 10:39:27 AM

Board Marks: 4

Posts Today: 0

Board Views Today: 57

Currenc Group Inc. (OTCMRKTS: CURR) Stock Message Board

1. CURR Company Profile

    

2. CURR Time & Sales

    

3. CURR Recent News

    

4. CURR Filings

    

5. CURR Financials

    

6. CURR Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

59	CURE Pharmaceutical Announces Teleconference (1)	Lee Adams	08/01/2022 9:33:14 AM
58	CURE Pharmaceutical Announces the Sale of a (1)	Lee Adams	07/28/2022 9:46:28 AM
57	CURE Pharmaceutical Announces Positive Findings	Lee Adams	05/12/2022 2:25:03 PM
56	$CURR presenting here: Keynotes, Educational	Lee Adams	04/27/2022 10:34:26 AM
55	$CURR News: Sera Labs Inc. Products Now Available	Lee Adams	04/14/2022 9:50:50 AM
54	CURE Pharmaceutical and Milagro Pharmaceuticals	Lee Adams	03/03/2022 11:44:16 AM
53	$CURR News: Sera Labs, a Subsidiary of CURE	Lee Adams	01/24/2022 9:29:28 AM
52	June 10, 2021 8:15 AM CURE Pharmaceutical Signs	Mauibound	06/19/2021 10:44:04 PM
51	Nicole Kidman and Sera Labs Inc., a CURE	Lee Adams	06/09/2021 10:33:48 AM
50	CURE Pharmaceutical Schedules Investor Webcast	Lee Adams	05/25/2021 10:03:43 AM
49	CURE Pharmaceutical First Quarter Revenue	Lee Adams	05/17/2021 9:42:14 AM
48	CURE Pharmaceutical Receives ISO Certification	Lee Adams	05/13/2021 10:43:37 AM
47	Nicole Kidman, Sera Labs Strategic Business	Lee Adams	04/28/2021 10:43:29 AM
46	CURE Pharmaceutical Announces Successful Results	Lee Adams	04/21/2021 9:57:31 AM
45	CURE Pharmaceutical to Present at the 2021	Lee Adams	04/19/2021 9:41:36 AM
44	Nicole Kidman, Sera Labs Strategic Business	Lee Adams	04/13/2021 10:10:30 AM
43	CURE Pharmaceutical Reports Increase in Revenue	Lee Adams	04/01/2021 9:49:45 AM
42	CURE Pharmaceutical Augments Its Existing U.S.	Lee Adams	03/23/2021 10:26:17 AM
41	CURE Pharmaceutical Launches Psychedelic Oral	Lee Adams	03/16/2021 10:03:50 AM
40	CURE Pharmaceutical Announces Addition of Two New	Lee Adams	03/10/2021 10:13:43 AM
39	CURE Pharmaceuticals Subsidiary Sera Labs	Lee Adams	03/03/2021 1:53:49 PM
38	CURE Pharmaceutical Announces the Initiation of	Lee Adams	02/23/2021 9:04:38 AM
37	CURE Pharmaceutical Announces Promotions and	Lee Adams	02/11/2021 9:42:16 AM
36	Sera Labs Unveils ImmunD an Important New	Lee Adams	02/10/2021 11:10:58 AM
35	CURE Pharmaceutical (Stock Symbol: CURR) is a	Lee Adams	02/05/2021 11:53:04 AM
34	CURE Pharmaceutical to Present at 2021 NobleCon17	Lee Adams	01/19/2021 9:42:07 AM
33	CURE Pharmaceutical to Present at H.C. Wainwright	Lee Adams	01/07/2021 9:53:46 AM
32	CURE Pharmaceutical Receives FDA Approval for its	Lee Adams	01/05/2021 9:17:55 AM
31	$CURR - Investor Video Webcast from December 17,	Lee Adams	12/23/2020 10:57:20 AM
30	CURR Form 4 Filed on Dec. 21st. CEO Robert	Lee Adams	12/21/2020 7:31:25 PM
29	CURE Pharmaceutical to Present at LD Micro on	Lee Adams	12/14/2020 12:32:19 PM
28	Nicole Kidman Partners With SeraLabs, a CURE	Lee Adams	12/08/2020 9:26:13 AM
27	CURR 32% v458K c1.64 f53,2M H2.12 S1.47	znewcar1	12/01/2020 10:47:07 PM
26	CURE Pharmaceutical Issues Letter to Shareholders	Lee Adams	11/18/2020 9:26:03 AM
25	$CURR CURE Pharmaceutical Closes $10 Million	stocksonhighalert	11/16/2020 12:48:57 PM
24	CURE Pharmaceutical to Present at Two Virtual	Lee Adams	09/02/2020 9:19:52 AM
23	Excellent video interview with SERA LABS CEO.	Lee Adams	08/27/2020 1:04:14 PM
22	CURR is starting to get more bio-industry	Lee Adams	08/21/2020 11:10:23 AM
21	$CURR News: CURE Pharmaceutical to Acquire Sera	trooperstocks	07/28/2020 9:01:58 AM
20	$CURR News: CURE Pharmaceutical CBD Oral Thin	trooperstocks	07/15/2020 8:13:34 AM
19	CURE Pharmaceutical Receives NSFs cGMP	Lee Adams	07/08/2020 9:29:23 AM
18	CURE Pharma's CEO, Rob Davidson, on Leveraging IP	Lee Adams	07/06/2020 10:38:27 AM
17	CURE Pharmaceutical Appoints Chief Business	Lee Adams	06/16/2020 9:31:07 AM
16	CURE Pharmaceutical Announces Exercise of	Lee Adams	06/09/2020 1:26:24 PM
15	CURE Pharmaceutical Expands to Mexico in	Lee Adams	06/03/2020 10:33:35 AM
14	At one time $AMBS was going to sell ELTO PHARMA	Mauibound	04/23/2020 2:27:13 AM
13	Todos Medical Appoints Dr. Lauren Chung to its	Mauibound	04/23/2020 2:04:34 AM
12	8-K Item 1.01. Entry Into A Material Definitive	Mauibound	04/23/2020 2:01:04 AM
11	CURE Pharmaceutical Expands Cannabis Extraction	Lee Adams	04/21/2020 11:26:34 AM
10	The CURR bio-technology platform offers truly	Lee Adams	04/16/2020 11:11:46 AM

Newer

Older

Recent Articles

• Kevin O'Leary Discusses Rising Business Costs and Hope for Change
• Opportunity Alert for Xiao-I Corporation Investors Ahead of Deadline
• Elon Musk's Support for Argentina's Tax Cuts Leaves Many Confused
• Elon Musk's Tweet on a Sink: Unpacking Its Mysterious Meaning
• North Korea's Oil and Military Dealings with Russia Explored
• Trump's Ambitious DOJ Revamp: What It Means for America
• Russell Vought Appointed as OMB Director by Trump
• RWA Inc Launches $RWA Token, Transforming Asset Tokenization
• Elon Musk Advocates for Release of Jeffrey Epstein Files
• Trudeau Denounces Violence Amid NATO Assembly in Montreal
• Chavez-DeRemer's Selection as Labor Secretary: What It Means
• Tesla Cybertruck: A New Role in Presidential Security?
• Representative Laurel Lee's Strategic Stock Moves in 2024
• Marjorie Taylor Greene Expands Investment Portfolio with Stocks
• Suzan K. DelBene's Strategic Investments in Government Securities
• Recent Sale of State Street Corporation Stock by Auchincloss
• Elon Musk's Post Ignites Dogecoin Growth Amid X Payments Buzz
• Global Cooperation on Carbon Credit Trading Sets Standards
• Iris Energy Limited Investors Must Act by December 6, 2024
• DEA's Random Search Ban: A Deep Dive into Corruption Findings
• Investors Take Action: Edwards Lifesciences Faces Lawsuit
• Brooke Rollins: A Potential New Face in U.S. Agriculture Leadership
• Goldman Sachs Faces Major Write-Off after Northvolt Bankruptcy
• Musk's Court Victory Against SEC Marks Key Legal Turning Point
• New U Life Triumphs in Legal Battle: Awakend's Appeal Failed
• Adani Energy Solutions Addresses Kenya Project Cancellation Impact
• Whale Activity in Dogecoin Surges with $214.5 Million Purchase
• Investors Urged to Act: Paragon 28 Lawsuit Insights
• Thanksgiving Costs and Travel Trends Amid Inflation Insights
• Market Movers: Insights on Coinbase, MicroStrategy, and More
• Bosch's Strategic Shift: Reducing Hours for Thousands in Germany
• Investigation of Mergers: MKFG, CYTH, BRKH, and CFB Explored
• Wolfspeed Investors: Join the Fight for Justice and Recovery
• Legal Action for ASML Investors: Take Charge Now
• Short Selling: A Growing Trend Amid Market Fluctuations
• Lead Class Action Opportunity for Hasbro Investors Amid Losses
• Xerox Holdings Corporation Class Action: Key Investor Info
• Election Outcomes Signal Shift in Housing Support and Strategies
• Mark Cuban Advocates for Leadership Growth Over Micromanagement
• Spirit Airlines Takes Strategic Step With Chapter 11 Filing
• Investors Urged to Join Class Action Against PACS Group Inc.
• Nvidia's Future Looks Bright as Chip Demand Remains Strong
• Robert Kiyosaki Champions Bitcoin Investment Strategy by Saylor
• Investors Encouraged to Seek Legal Counsel for $JENNER Case
• UPS and BIT Mining Fined in Major Financial Misconduct Cases
• Allan Leighton Returns to Lead Asda as Executive Chairman
• Kaskela Law Investigates Innovid Corp. Buyout Deal for Investors
• Concerns Arise Over Zuora, Inc. Shareholder Privileges Amid Acquisition
• MicroStrategy's Michael Saylor Hails $500M Daily Profit from Bitcoin
• Empowering Lilium N.V. Investors: Your Rights and Options